Beyer D, Vannuffel P, Pepper K
Rhône-Poulenc Rorer S.A., Centre de Recherche, Vitry sur Seine, France.
Biol Chem. 1998 Jul;379(7):841-6. doi: 10.1515/bchm.1998.379.7.841.
Streptogramin antibiotics consist of two types of molecules, group A and group B. The group B molecule quinupristin (RP 57669) and the group A molecule dalfopristin (RP 54476) constitute the first water-soluble semisynthetic streptogramin, quinupristin/dalfopristin (RP 59500). When group B molecules bind to 50S subunits or to tightly coupled ribosomes, there is an increase in their fluorescence intensity, which is proportional to the concentration of the antibiotic-ribosome complex formed. We found here that the background fluorescence of unbound quinupristin is 10-fold lower than that of unbound virginiamycin S, a natural group B molecule often used experimentally. The association constants were found (i) to be similar for the binding of the two group B molecules to tightly coupled 70S ribosomes in the absence of the group A molecules (quinupristin: 3.5 x 10(7) M(-1); virginiamycin S: 2.8 x 10(7) M(-1)) and (ii) to similarly increase about 20-fold in the presence of the corresponding group A molecule (quinupristin + dalfopristin: 69 x 10(7) M(-1); virginiamycin S + virginiamycin M: 60 x 10(7) M(-1)). Similar results were obtained with 50S ribosomal subunits. Additionally, we provide evidence that the failure of the group B molecules to inhibit poly(Phe) synthesis is due to the displacement of the group B molecule during poly(Phe) polymerization on the ribosome, indicating that the artificial poly(Phe) peptide competes with the binding of the group B molecule.
链阳菌素类抗生素由A组和B组两种类型的分子组成。B组分子奎奴普丁(RP 57669)和A组分子达福普汀(RP 54476)构成了首个水溶性半合成链阳菌素,即奎奴普丁/达福普汀(RP 59500)。当B组分子与50S亚基或紧密偶联的核糖体结合时,其荧光强度会增加,且与形成的抗生素 - 核糖体复合物的浓度成正比。我们在此发现,未结合的奎奴普丁的背景荧光比未结合的维吉尼亚霉素S低10倍,维吉尼亚霉素S是一种常用于实验的天然B组分子。结果发现,(i)在不存在A组分子的情况下,两种B组分子与紧密偶联的70S核糖体结合的缔合常数相似(奎奴普丁:3.5×10⁷ M⁻¹;维吉尼亚霉素S:2.8×10⁷ M⁻¹),(ii)在相应A组分子存在的情况下,缔合常数同样会增加约20倍(奎奴普丁 + 达福普汀:69×10⁷ M⁻¹;维吉尼亚霉素S + 维吉尼亚霉素M:60×10⁷ M⁻¹)。使用50S核糖体亚基也获得了类似结果。此外,我们提供的证据表明,B组分子未能抑制多聚苯丙氨酸(poly(Phe))合成是由于在核糖体上进行多聚苯丙氨酸聚合过程中B组分子被取代,这表明人工合成的多聚苯丙氨酸肽与B组分子的结合存在竞争。